OR WAIT null SECS
October 14, 2017
Samsung BioLogics’ second facility adds 152,000 L of mAb drug substance capacity.
October 10, 2017
Hitachi Chemical Advanced Therapeutics Solutions will expand its PCT service platform for cell therapy by adding GMP manufacturing and cleanroom capacity in Allendale, NJ.
September 02, 2017
Innovation speeds discovery, drives down costs, and improves productivity.
July 05, 2017
Samsung BioLogics signs $55.5 million agreement to manufacture tildrakizumab for Sun Pharma.
June 02, 2017
Although widespread adoption of continuous bioprocessing has been slow, some processes have been an exception.
May 15, 2017
Catalent has signed an agreement with Therachon to support preclinical and clinical development of TA-46, a novel protein being developed to treat achondroplasia.
February 01, 2017
Cold-chain requirements and the tight logistical windows needed for cell and gene therapies demand a focus on early communication and risk mitigation.
December 21, 2016
AGC adds second biopharma contract manufacturer with acquisition of CMC Biologics.
October 24, 2016
Catalent invests $34 million to add a 2 x 2000-L single-use bioreactor system and laboratory space in Madison, WI.
June 07, 2016
Uncertainty about the demand for a biologic medication can be partly mollified with some well-planned capacity outsourcing, contends a new report by ORC International sponsored by Patheon.